Concepedia

Philipp Müller

PM

Statistics

Publications

34

Citations

2K

H-Index

21

Active since

1982

Affiliations

Novartis (Switzerland)(Current)

Tampere University

University of Bern

Institute of Social and Preventive Medicine

Philipp Müller is an author at Novartis (Switzerland) specializing in pharmacology, transdermal drug delivery, and medicine.

Publications per year

1982–2023

34

Publications

34

Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure

Wolfgang Kiowski, J Kim, Erwin Oechslin et al. · The Lancet · 1995 · 573 citations

Life Sciences, Cardiology, Physiology +11

CONTROLLED TRIAL OF TRANSDERMAL NICOTINE PATCH IN TOBACCO WITHDRAWAL

T Abelin, Philipp Müller, Adrian Büehler et al. · The Lancet · 1989 · 202 citations

Public Health, Pharmacotherapy, Substance Use Disorders +9

Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man

Gérard Flesch, Philipp Müller, Peter Lloyd · European Journal of Clinical Pharmacology · 1997 · 201 citations

Medicine, Pharmacokinetics, Pharmacology +11

Human pharmacological studies of a new transdermal system containing nitroglycerin

Philipp Müller, P Imhof, F Burkart et al. · European Journal of Clinical Pharmacology · 1982 · 140 citations

Pharmacy, Pharmacology, Bioavailability +12

Effectiveness of a transdermal nicotine system in smoking cessation studies.

T Abelin, Rolf Ehrsam, A Bühler-Reichert et al. · PubMed · 1989 · 77 citations

Public Health, Pharmacology, Pharmacotherapy +17

1–5 of 34